12 March 2015Americas

Bard lands injunction against blood clot powder rival CryoLife

A judge at the US District Court for the District of Delaware has issued a preliminary injunction against CryoLife, finding that the medical device maker’s PerClot Topical haemostatic powder infringes rival company C R Bard’s patent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk